Brilaroxazine
RVP-30-001 RECOVER
Phase 3 small_molecule active
Quick answer
Brilaroxazine for Schizophrenia is a Phase 3 program (small_molecule) at REVIVA PHARMACEUTICALS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Indication
- Schizophrenia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active